Patent · US Active

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

US10829552B2 · kind B2 · utility

0Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2018
Grant dateNov 10, 2020
Priority date
Expiry dateJun 7, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to amino acid sequences that are directed against (as defined herein) any of IL-17A, IL-17F and/or IL-17A/F including combinations thereof, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.